Matthew L. Posard - 09 Jun 2023 Form 4 Insider Report for Talis Biomedical Corp (TLIS)

Role
Director
Signature
/s/ Gillian Green, Attorney-in-fact for Matthew L. Posard
Issuer symbol
TLIS
Transactions as of
09 Jun 2023
Transactions value $
$0
Form type
4
Filing time
12 Jun 2023, 17:28:05 UTC
Previous filing
05 Jun 2023
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock option (right to buy) Award $0 +95K $0.00 95K 09 Jun 2023 Common Stock 95K $0.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares subject to the option shall vest monthly over one year from the vesting commencement date.